Sunday, April 10, 2011

Rifaximin Effective in IBS

Note: Antibiotics target bacteria not viruses, however it is possible
to have a combination of bacteria and viruses affecting the body at
the same time. IBS is one of several disorders that have been termed
Functional Somatic Syndromes or which adherents of the social medicine
theory of "medicalization" have stated are conditions "created" by
pharmaceutical companies to sell drugs. The results of this study
indicate that neither of those theories are accurate.

Antibiotic Rifaximin Extremely Effective In Irritable Bowel Syndrome Treatment
Christian Nordqvist

06 Jan 2011

Rifaximin, a minimally absorbed antibiotic that stays in the gut has
been found to provide long-lasting relief for patients with irritable
bowel syndrome (IBS), researchers have revealed in NEJM (New England
Journal of Medicine). IBS patients experienced relief long after they
had stopped taking the drug.

The authors report that patients reported relief from IBS symptoms for
up to 10 weeks after completing rifaximin treatment. They specifically
reported considerable reductions in abdominal pain, bloating, and
better stool consistency.

The authors explain that the idea that bacteria play a major role in
IBS has been disputed over the last ten years. These latest findings
confirm that intestinal bacteria, also known as the gut microbiome,
are closely involved in IBS symptoms...

"Rifaximin Therapy for Patients with Irritable Bowel Syndrome without
Constipation"

Mark Pimentel, M.D., Anthony Lembo, M.D., William D. Chey, M.D., Salam
Zakko, M.D., Yehuda Ringel, M.D., Jing Yu, Ph.D., Shadreck M. Mareya,
Ph.D., Audrey L. Shaw, Ph.D., Enoch Bortey, Ph.D., and William P.
Forbes, Pharm.D. for the TARGET Study Group
N Engl J Med 2011; 364:22-32January 6, 2011


Copyright: Medical News Today


Full article URL: http://www.medicalnewstoday.com/articles/212981.php

No comments: